The Cass Review provides guidance on gender-affirming care: SA’s medical community is now at a crossroads

The question as to the best approach to providing care for children and young people with gender dysphoria or gender incongruence is complex, contested, and controversial, both in South Africa and globally. Following the release of a major new report in the United Kingdom, it is clear that a change of course is needed in South Africa, argue doctors Janet Giddy, Allan Donkin, and associate professor Reitze Rodseth.

Read More

#Vote4Health | What 10 political parties have to say on Spotlight’s top 7 health questions

Healthcare is an issue that at some point touches everyone in South Africa. It is also an issue that will impact who people vote for on the 29th of May. To help voters understand just what parties are putting on the table when it comes to healthcare, Spotlight pin-pointed seven critical healthcare questions and put them to 10 political parties.

Read More

A humanist with an unblinking gaze – Professor Ntobeko Ntusi takes the hot-seat at the South African Medical Research Council

Professor Ntobeko Ntusi may be softspoken, but he is not afraid to stand by his strongly held views. As he is set to take up the hot-seat at the country’s primary health research funder, he tells Spotlight’s Biénne Huisman about his background and his priorities for the new job.

Read More

#InTheSpotlight | Diabetes is a leading killer in SA – yet we don’t know who has it or where they are

Diabetes is the second leading cause of death in South Africa after tuberculosis, according to Statistics South Africa. It is the leading cause of death in women. Yet, despite being a major driver of deaths and illness, we do not have a clear picture of how many people in the country have diabetes or how many people are receiving diabetes care. This leaves our health system ill-equipped to handle the growing diabetes crisis.

Read More

Widely used HIV drug in SA flagged for reports of resistance – but experts say don’t panic

That HIV can develop resistance to the drugs used to treat it is nothing new, but results from recent studies reveal the emergence of resistance in subsets of people living with HIV to dolutegravir – an antiretroviral widely used in South Africa. Top HIV experts spoke to Elri Voigt about the new findings and what it means for people living with HIV in the country.

Read More